Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug for treatment of asthenozoospermia

A technology for asthenozoospermia and drugs, applied in the directions of drug combination, pharmaceutical formula, plant raw materials, etc., can solve the problems of insignificant treatment effect, large side effects, high treatment cost, etc., and achieve low treatment cost, small side effects, and good curative effect. Effect

Inactive Publication Date: 2013-11-20
TIANJIN PACIFIC PHARMA
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The purpose of the present invention is to overcome the disadvantages of inconspicuous therapeutic effect, large side effects and high cost of treatment, and provide a medicine for treating asthenospermia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] A medicine for treating asthenospermia, comprising: curculigo, celestial spleen, dodder, yam, hippocampus, mulberry, rehmannia glutinosa, dogwood, alisma, poria cocos and licorice, wherein the weight-to-number ratio of each component is:

[0045] Curculigo 9 servings

[0046] 8 servings of fairy spleen

[0047] Cuscuta 12 servings

[0048] 9 servings of yam

[0049] 13 servings of seahorse

[0050] Sang Jisheng 9 servings

[0051] Rehmannia glutinosa 9 parts

[0052] 8 servings dogwood

[0053] Alisma 11 servings

[0054] Poria cocos 12 parts

[0055] Licorice 8 parts

Embodiment 2

[0057] A medicine for treating asthenospermia, comprising: curculigo, celestial spleen, dodder, yam, hippocampus, mulberry, rehmannia glutinosa, dogwood, alisma, poria cocos and licorice, wherein the weight-to-number ratio of each component is:

[0058] Curculigo 12 parts

[0059] 8 servings of fairy spleen

[0060] Cuscuta 12 servings

[0061] 9 servings of yam

[0062] 12 seahorses

[0063] Sang Jisheng 9 servings

[0064] Rehmannia glutinosa 12 parts

[0065] 8 servings dogwood

[0066] Alisma 11 servings

[0067] Poria cocos 12 parts

[0068] Licorice 8 parts

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a drug for treatment of asthenozoospermia, and the drug comprises the following materials: by weight, 8-15 parts of curculigo orchioides, 6-12 parts of herba epimedii, 10-15 parts of semen cuscutae, 8-12 parts of Chinese yam, 12-18 parts of hippocampus, 8-12 parts of loranthus parasiticus, 8-15 parts of prepared rehmannia root, 7-11 parts of cornus officinalis, 8-12 parts of rhizoma alismatis, 10-18 parts of poria cocos and 8-12 parts of licorice. The drug for treatment of asthenozoospermia has the advantages and positive effects of good curative effect, small side effect and low treatment cost.

Description

technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a medicine for treating asthenospermia. Background technique [0002] Asthenozoospermia refers to less than 50% of the sperm moving forward in the semen parameters. Asthenospermia is also called low sperm motility. Western medicine believes that the reasons are complex, mainly caused by genetic diseases, congenital dysplasia, endocrine factors, vas deferens blockage, reproductive tract infection, immune factors, drug factors, environmental factors, bad living habits, etc. The current method of treating this disease is based on Chinese patent medicines, but most of the Chinese patent medicines on the market have ineffective effects, high drug prices, and many side effects. Contents of the invention [0003] The purpose of the invention is to overcome the shortcomings of inconspicuous therapeutic effect, large side effects and high treatment cost, and provide a medicine for tre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8945A61P15/08A61K35/56A61K35/60
Inventor 宋德成邸克莱刘彩田王磊
Owner TIANJIN PACIFIC PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com